Skip to content 
Best of NH, Three Times Over: Thank You, Salem (and Beyond)
August 3, 2026
By Jessica St. Jean, MSN, FNP-C | JSJ Aesthetics
If you’ve been following peptide therapy in the wellness and longevity space, you’ve probably seen the headlines this summer: “FDA clears BPC-157.”
As a nurse practitioner who fields these questions from patients almost daily, I’m excited about what’s actually happening here. It’s one of the biggest steps forward for peptide therapy in years, and I want to walk you through exactly what it means so you can see why this matters.
What Actually Happened
On July 23-24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) met to review seven peptides that have built a strong following in wellness and regenerative medicine circles.
The committee’s job was to decide whether each peptide should be added to the Section 503A Bulks List: the list that allows licensed compounding pharmacies to legally prepare a substance for patients under a valid prescription.
The result was a clear win for the field:
- Six of the seven peptides received a favorable recommendation.
- This opens the door to these therapies being sourced from FDA-registered manufacturers and prepared by licensed compounding pharmacies, under real physician oversight.
- It’s a major step away from the gray-market products patients have relied on for years, and toward a trusted, clinically supervised pathway.
The Outcome, Peptide By Peptide
Here’s where each of the peptides you may have heard about landed, along with the specific use the FDA reviewed for each:
- BPC-157: reviewed for ulcerative colitis. Recommended (8-6 vote).
- KPV: reviewed for wound healing and inflammatory conditions. Recommended (8-6 vote).
- TB-500: reviewed for wound healing. Recommended (8-6 vote).
- MOTS-C: reviewed for obesity and osteoporosis. Recommended (7-5 vote).
- Epitalon: reviewed for insomnia. Recommended (7-4 vote).
- Semax: reviewed for cerebral ischemia, migraine, and trigeminal neuralgia. Recommended (8-5 vote).
- Emideltide / DSIP (delta sleep-inducing peptide): reviewed for opioid withdrawal, chronic insomnia, and narcolepsy. This one did not receive a favorable vote this round (6-7).
Six favorable recommendations out of seven is a strong signal of where this field is headed.
What Happens Next
A couple of quick, practical points so you know how to think about timing:
- The recommendations now move to formal FDA rulemaking, generally an 8-12 month process.
- Once finalized, these peptides can be legally compounded by a licensed pharmacy under a prescription from a provider like myself, who evaluates whether it’s the right fit for you.
- This is different from a peptide being an “FDA-approved drug” in the traditional sense (like a medication with its own brand-name approval). Instead, it’s the regulatory pathway that lets your provider and a licensed pharmacy work together to bring you a properly sourced, quality-controlled version of these therapies, rather than something ordered online with no oversight.
That distinction is actually good news for patients: it means real accountability, real sourcing standards, and a real clinician involved in your care.
Why This Is Exciting For Our Patients
This shift strengthens the pathway even further for patients who want peptide therapy done right:
- Peptides sourced from FDA-registered manufacturers
- Prepared by licensed compounding pharmacies
- Prescribed by a provider who knows your history and goals
That’s exactly the kind of framework we’ve been hoping to see, and it’s why we’re watching this process closely and are ready to guide our patients through it as it becomes available.
Curious If Peptide Therapy Is Right For You?
Peptide therapy has generated real interest for good reason: patients are looking for options that support healing, metabolic health, sleep, and recovery.
As this pathway opens up, we want you to have a provider in your corner who understands both the science and the regulatory landscape, so you can make a confident, informed decision.
Schedule a consultation with our team to talk through your goals and where peptide therapy in Medford MA or Salem NH may fit into your care plan.
